Q) What is the most suitable treatment option for non muscle-invasive bladder cancer with the risk of recurrences? A)Cystectomy B)Intravesical chemotherapy C)Transurethral resection and adjuvant intravesical chemotherapy D)Palliative therapy Uro Onco MCQS
Q) What is the correct regarding squamous cell carcinoma? (For oncosurgery skin MCQs see here) A)Chronic healing wound is a risk factor. B)Bowen’s disease does not have a risk of malignant transformation. C)In situ disease present as slightly pink or skin coloured raised plaques. D)Imiquimod is not used as a treatment option.
Q ) Biliary stricture in chronic pancreatitis. True Statement is a) Endoscopy is primary treatment b) Mostly asymptomatic c) Stricture is because of proximity to head of pancreas d) Malignancy must always be ruled out
Q ) 3.5cm mass in nasopharynx extending to left nasal cavity with 4.5cm size LN in supraclavicular area. staging, a.T1N1 B.T1N3 C.T2N1 D.T2N3
Q) Choledochal cyst III, treatment (MCH GI 2019) A) Partial hepatic resection B) Choledochojejunostomy C) Transduodenal excision D) Endoscopic drainage
Q) False statement about esophagus duplication cyst a) Cystic form is most common which does not communicate with the lumen b) Adults are mostly asymptomatic c) Malignnat transformation is rare d) Most commonly seen in middle 1/3 of esophagus
Q) What is not true regarding Sugiura’s procedure for Portal Hypertension a) It is a transesophageal variceal ligation b) Splenectomy is done c) Vagotomy d) Pyloroplasty Sugiura procedure is the nonshunting procedure for EV bleeding, which was first proposed by Sugiura and Futagawa in 1973 [2]. However, because of its complexity and high postoperative morbidity and mortality, this procedure has not been widely accepted in Western countries
Q. Most important prognostic factor for carcinoma esophagus is a) Cellular differentiation b) Depth of esophagus involvement c) length of esophagus involvement d) age of the patient Questions